On December 28,2024, Hunan Suoyuan Chinese Medicinal Materials Co., Ltd. (hereinafter referred to as "Suoyuan Company") held its annual work conference to mark its second anniversary. The event was attended by Shen Fanshun, Party Branch Secretary and Chairman of Chun Guang Jiu Hui, along with the company's leadership team and all employees. They gathered to review the past year's achievements and chart the course for future development.

At the meeting, Xiao Jianbo, Executive Director and General Manager of Hunan Suoyuan Chinese Medicinal Materials Co., Ltd., delivered a comprehensive review of the company's 2024 performance. He conducted a thorough analysis of existing challenges and outlined the strategic objectives for 2025, along with key initiatives to be prioritized.

In 2024, guided by the annual targets, all employees of Suyuan Company worked in unity and made significant progress in completing key tasks. Notably, they achieved outstanding results in ensuring the supply of substandard medicinal materials, implementing designated procurement for herbs, and advancing rural revitalization initiatives. These steady business developments have further solidified the foundation for the company's future growth.

During the meeting, participants actively discussed the work report, addressing issues at Suyuan Company, including its development direction, goals, implementation strategies, and related measures, engaging in thorough exchanges.

In his concluding remarks, Shen Fanshun fully acknowledged the achievements of Suyuan Company in 2024, provided key guidance for the 2025 operational targets, and set higher expectations.

He emphasized that excelling in business means being the right person doing the right thing at the right time. To achieve this, Suyuan Company must focus on three key strategies: First, prioritize team building and talent development, ensuring that specialized tasks are handled by qualified professionals. Second, capitalize on the growing opportunities created by increased financial and policy support for the traditional Chinese medicine industry from the national government, Hunan Province, and Yifa Group, and leverage these trends to expand and strengthen the company. Third, adopt a problem-oriented approach guided by clear objectives, evaluate performance based on tangible results, and continuously learn from successes and failures to refine strategies. This will help build and continuously enhance Suyuan Company's core competitiveness.

The meeting also recognized the 'Outstanding Team' and 'Outstanding Employee' awards from the Traceability Company.

The annual work conference not only laid a solid foundation for Suyuan Company's future development but also infused new vitality and confidence into its employees. Going forward, Suyuan will tackle challenges head-on and spare no effort to ensure the supply of medicinal materials required for Chun Guang Jiu Hui production. Meanwhile, the company will accelerate its transformation into a business model focused on upstream resource sourcing and strategic medicinal material reserves.